Kah Meng Lim
Chief Executive Officer bei COMPASS VENTURE INC.
Vermögen: 64 800 $ am 30.11.2023
Profil
Kah Meng Lim is the founder of Gene Oasis Pte Ltd.
He is currently the Chief Executive Officer & Director at Compass Venture, Inc., Chief Executive Officer at Zenzic Labs Pte Ltd., Chief Executive Officer at NGF Bioenterprise Pte Ltd., Director at GDX Corp., Independent Non-Executive Director at Singapore Paincare Holdings Ltd., Director at CanniOasis Pte Ltd., and Director at Betalife Pte Ltd.
Dr. Lim previously worked as an Associate Professor at Tianjin University from 2014 to 2017.
He received his doctorate degree from Yong Loo Lin School of Medicine in 2001.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
COMPASS VENTURE, INC.
7,08% | 26.10.2022 | 400 000 ( 7,08% ) | 64 800 $ | 30.11.2023 |
Aktive Positionen von Kah Meng Lim
Unternehmen | Position | Beginn |
---|---|---|
COMPASS VENTURE INC. | Chief Executive Officer | 02.01.2019 |
SINGAPORE PAINCARE HOLDINGS LIMITED | Director/Board Member | 05.03.2021 |
Zenzic Labs Pte Ltd. | Chief Executive Officer | 01.01.2019 |
NGF Bioenterprise Pte Ltd. | Chief Executive Officer | 01.01.2017 |
GDX Corp. | Director/Board Member | 01.01.2019 |
Ehemalige bekannte Positionen von Kah Meng Lim
Unternehmen | Position | Ende |
---|---|---|
Tianjin University | Corporate Officer/Principal | 01.01.2017 |
Gene Oasis Pte Ltd. | Founder | - |
Ausbildung von Kah Meng Lim
Yong Loo Lin School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SINGAPORE PAINCARE HOLDINGS LIMITED | Health Services |
Private Unternehmen | 5 |
---|---|
GDX Corp. | |
Compass Venture, Inc. | |
Zenzic Labs Pte Ltd. | |
NGF Bioenterprise Pte Ltd. | |
Gene Oasis Pte Ltd. |